Tumour stimulating effects of recombinant human interleukin-6

Lancet. 1994 Dec 3;344(8936):1576-7. doi: 10.1016/s0140-6736(94)90387-5.
No abstract available

Publication types

  • Clinical Trial
  • Clinical Trial, Phase I
  • Letter

MeSH terms

  • Adult
  • Carcinoma, Renal Cell / pathology
  • Carcinoma, Renal Cell / therapy*
  • Female
  • Humans
  • Interleukin-6 / adverse effects*
  • Kidney Neoplasms / pathology
  • Kidney Neoplasms / therapy*
  • Liver Neoplasms / secondary
  • Liver Neoplasms / therapy*
  • Lung Neoplasms / secondary
  • Male
  • Middle Aged
  • Retrospective Studies

Substances

  • Interleukin-6